Journal
SEMINARS IN IMMUNOPATHOLOGY
Volume 41, Issue 2, Pages 265-275Publisher
SPRINGER HEIDELBERG
DOI: 10.1007/s00281-018-0716-7
Keywords
Adaptive immunity; Innate immunity; Sex differences; Sex hormones; Probiotics; Faecal microbiota transplant; Bacteriotherapy
Categories
Funding
- NIH/NIAID Center of Excellence in Influenza Research and Surveillance [HHS N272201400007C]
- NHMRC CJ Martin Fellowship [1091097]
- Victorian Government's Operational Infrastructure Support Program
- NHMRC Senior Research Fellowship
- Clifford Craig Foundation
- National Health and Medical Research Council of Australia [1091097] Funding Source: NHMRC
Ask authors/readers for more resources
Sex differences in immunity are well described in the literature and thought to be mainly driven by sex hormones and sex-linked immune response genes. The gastrointestinal tract (GIT) is one of the largest immune organs in the body and contains multiple immune cells in the GIT-associated lymphoid tissue, Peyer's patches and elsewhere, which together have profound effects on local and systemic inflammation. The GIT is colonised with microbial communities composed of bacteria, fungi and viruses, collectively known as the GIT microbiota. The GIT microbiota drives multiple interactions locally with immune cells that regulate the homeostatic environment and systemically in diverse tissues. It is becoming evident that the microbiota differs between the sexes, both in animal models and in humans, and these sex differences often lead to sex-dependent changes in local GIT inflammation, systemic immunity and susceptibility to a range of inflammatory diseases. The sexually dimorphic microbiome has been termed the microgenderome'. Herein, we review the evidence for the microgenderome and contemplate the role it plays in driving sex differences in immunity and disease susceptibility. We further consider the impact that biological sex might play in the response to treatments aimed at manipulating the GIT microbiota, such as prebiotics, live biotherapeutics, (probiotics, synbiotics and bacteriotherapies) and faecal microbial transplant. These alternative therapies hold potential in the treatment of both psychological (e.g., anxiety, depression) and physiological (e.g., irritable bowel disease) disorders differentially affecting males and females.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available